INHIBITOR THERAPTICS INC (INTI) earnings
Quarterly and annual INTI reports and results, each read against the price at its own news timestamp. Back to the INTI overview →
12 measured INTI earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Inhibitor Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.11% | |
| Form 10-Q Inhibitor Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Inhibitor Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -10.00% | -10.00% | |
| Form 10-Q Inhibitor Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Inhibitor Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-Q Inhibitor Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +77.37% | |
| Form 10-K Inhibitor Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -9.58% | -9.58% | |
| Form 10-Q Inhibitor Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Inhibitor Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Inhibitor Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-K Inhibitor Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -12.10% | |
| Form 10-Q Inhibitor Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -41.35% | -41.35% |
Keep exploring
More INTI: analyst actions → · SEC filings → · INTI overview →